Folic acid and Gemzar drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Folic acid (folic acid) and Gemzar (gemcitabine hydrochloride). Common drug interactions include pain among females and malignant neoplasm progression among males.
The phase IV clinical study analyzes what interactions people have when they take Folic acid and Gemzar. It is created by eHealthMe based on reports of 246 people who take the same drugs from the FDA, and is updated regularly.
What is Folic acid?
Folic acid has active ingredients of folic acid. It is often used in rheumatoid arthritis. eHealthMe is studying from 165,028 Folic acid users. Check the latest studies of Folic acid.
What is Gemzar?
Gemzar has active ingredients of gemcitabine hydrochloride. It is often used in pancreatic carcinoma. eHealthMe is studying from 20,315 Gemzar users. Check the latest studies of Gemzar.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
246 people who take Folic acid and Gemzar together, and have interactions are studied.
What are the common drug interactions of Folic acid and Gemzar, by gender? *
What are the common drug interactions of Folic acid and Gemzar, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Folic acid and Gemzar?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Folic acid (165,028 reports)
- Gemzar (20,315 reports)
Browse all drug interactions of Folic acid and Gemzar:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Folic acid:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Gemzar:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Folic acid and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Gemzar and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on folic acid and gemcitabine hydrochloride (the active ingredients of Folic acid and Gemzar, respectively), and Folic acid and Gemzar (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Actemra cause Labyrinthitis? - 3 seconds ago
- Could Metoclopramide cause Infusion Site Haemorrhage? - 14 seconds ago
- Could Flovent Hfa cause Bipolar Disorder? - 14 seconds ago
- Could Flovent Hfa cause Bi-Polar? - 14 seconds ago
- Could Metoclopramide cause Peritoneal Tuberculosis? - 15 seconds ago
- Drug interactions of Bisoprolol Fumarate and Liver Oil - 16 seconds ago
- Could Cimetidine cause Vomiting Aggravated? - 18 seconds ago
- Could Aciphex cause Sluggishness? - 19 seconds ago
- Could Rabeprazole Sodium cause Hyperhidrosis? - 19 seconds ago
- Could Cimzia cause Breast Pain? - 20 seconds ago